1. Home
  2. ATRA

ATRA

Atara Biotherapeutics Inc.

Logo Atara Biotherapeutics Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Founded: 2012 Country:
United States
United States
Employees: N/A City: THOUSAND OAKS
Market Cap: 84.5M IPO Year: 2014
Target Price: $8.37 AVG Volume (30 days): 2.8M
Analyst Decision: Hold Number of Analysts: 8
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.61 EPS Growth: N/A
52 Week Low/High: $0.20 - $3.08 Next Earning Date: 05-06-2024
Revenue: $8,573,000 Revenue Growth: -86.51%
Revenue Growth (this year): 1095.38% Revenue Growth (next year): -17.33%

Share on Social Networks: